BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7497464)

  • 1. Peritoneal exfoliative cytology and Ki-ras mutational analysis in patients with pancreatic adenocarcinoma.
    Rall CJ; Rivera JA; Centeno BA; Fernandez-del Castillo C; Rattner DW; Warshaw AL; Rustgi AK
    Cancer Lett; 1995 Nov; 97(2):203-11. PubMed ID: 7497464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.
    Van Laethem JL; Vertongen P; Deviere J; Van Rampelbergh J; Rickaert F; Cremer M; Robberecht P
    Gut; 1995 May; 36(5):781-7. PubMed ID: 7797131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
    Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
    Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of c-Ki-ras mutation by PCR/RFLP analysis and diagnosis of pancreatic adenocarcinomas.
    Urban T; Ricci S; Grange JD; Lacave R; Boudghene F; Breittmayer F; Languille O; Roland J; Bernaudin JF
    J Natl Cancer Inst; 1993 Dec; 85(24):2008-12. PubMed ID: 7902444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-Ki-ras mutations in peripheral blood of pancreatic cancer patients: a marker for early tumor metastasis.
    Mohiuddin M; Ahmed MM; Venkatasubbarao K
    Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):161-6. PubMed ID: 12118546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of K-ras oncogene mutations in pancreatic carcinoma: detection of micrometastases.
    Nomoto S; Nakao A; Ando N; Takeda S; Kasai Y; Inoue S; Kaneko T; Takagi H
    Semin Surg Oncol; 1998; 15(1):40-6. PubMed ID: 9671955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of minute cancer cell dissemination in peritoneal lavage fluid detected by reverse transcription PCR is an independent prognostic factor in patients with resectable pancreatic cancer.
    Eguchi H; Ohigashi H; Takahashi H; Yano M; Motoori M; Miyashiro I; Kishi K; Ohue M; Noura S; Seki Y; Yamada T; Goto K; Yamamoto T; Idota A; Fujii J; Nakajima H; Yamasaki T; Ishikawa O
    Surgery; 2009 Nov; 146(5):888-95. PubMed ID: 19744431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Peritoneal Staging for Pancreatic Ductal Adenocarcinoma Using Mutant KRAS Droplet-Digital Polymerase Chain Reaction: Results of a Prospective Clinical Trial.
    Yonkus JA; Alva-Ruiz R; Abdelrahman AM; Leiting JL; Schneider AR; Grotz TE; Cleary SP; Smoot RL; Nagorney DM; Kendrick ML; Kipp BR; Truty MJ
    J Am Coll Surg; 2021 Jul; 233(1):73-80.e1. PubMed ID: 34022414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ki-ras codon 12 point and P53 mutations: a molecular examination of the main tumor, liver, portal vein, peripheral arterial blood and para-aortic lymph node in pancreatic cancer.
    Yamaguchi K; Chijiiwa K; Torato N; Kinoshita M; Tanaka M
    Am J Gastroenterol; 2000 Aug; 95(8):1939-45. PubMed ID: 10950039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection.
    Kelly KJ; Wong J; Gladdy R; Moore-Dalal K; Woo Y; Gonen M; Brennan M; Allen P; Fong Y; Coit D
    Ann Surg Oncol; 2009 Dec; 16(12):3333-9. PubMed ID: 19763694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma.
    Ando N; Nakao A; Nomoto S; Takeda S; Kaneko T; Kurokawa T; Nonami T; Takagi H
    Pancreas; 1997 Nov; 15(4):374-8. PubMed ID: 9361091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gene diagnosis of pancreatic adenocarcinoma].
    Wang ZY; Liu TH; Cui QC
    Zhonghua Bing Li Xue Za Zhi; 1994 Oct; 23(5):270-3. PubMed ID: 7874757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis.
    Inoue S; Nakao A; Kasai Y; Harada A; Nonami T; Takagi H
    Jpn J Cancer Res; 1995 Jul; 86(7):626-30. PubMed ID: 7559078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal washing cytology combined with immunocytochemical staining and detecting mutant K-ras in pancreatic cancer: comparison of the sensitivity and availability of various methods.
    Nomoto S; Nakao A; Kasai Y; Inoue S; Harada A; Nonami T; Takagi H
    Pancreas; 1997 Mar; 14(2):126-32. PubMed ID: 9057184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
    Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
    Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative analysis of K-ras gene mutation in pancreatic tissue obtained by endoscopic ultrasonography-guided fine needle aspiration: clinical utility for diagnosis of pancreatic tumor.
    Tada M; Komatsu Y; Kawabe T; Sasahira N; Isayama H; Toda N; Shiratori Y; Omata M
    Am J Gastroenterol; 2002 Sep; 97(9):2263-70. PubMed ID: 12358243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
    Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
    Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry and molecular detection of nodal micrometastases in pancreatic cancer.
    Brown HM; Ahrendt SA; Komorowski RA; Doffek KM; Wilson SD; Demeure MJ
    J Surg Res; 2001 Feb; 95(2):141-6. PubMed ID: 11162037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of K-ras and c-erbB-2 mutations in pancreatic adenocarcinoma and chronic pancreatitis.
    Talar-Wojnarowska R; Gasiorowska A; Smolarz B; Romanowicz-Makowska H; Strzelczyk J; Janiak A; Kulig A; Malecka-Panas E
    Int J Gastrointest Cancer; 2005; 35(1):33-41. PubMed ID: 15722572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.